Paris-Saclay Cancer Cluster
Overview
Paris-Saclay Cancer Cluster is a non-profit biocluster and scientific cooperation foundation designed to accelerate innovation in oncology by uniting and supporting researchers, startups, hospitals, and industrial partners.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cereus Biosciences | - | Accelerator | Co-investor |
| Abbelight | Jun 2026 | Grant | Co-investor |
| Kindling Bio | Dec 2025 | Grant | Co-investor |
| Hope Valley AI | Apr 2024 | Accelerator | Co-investor |
| Skymab Biotherapeutics | Jun 2026 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Paris-Saclay Cancer Cluster based?
Paris-Saclay Cancer Cluster is headquartered in Villejuif, France.
When was Paris-Saclay Cancer Cluster founded?
Paris-Saclay Cancer Cluster was founded in 2022.
How many portfolio companies does Paris-Saclay Cancer Cluster have?
Paris-Saclay Cancer Cluster has 5 portfolio companies in Caplight's dataset.
What are some companies in Paris-Saclay Cancer Cluster's portfolio?
Portfolio companies visible on Caplight include Cereus Biosciences, Abbelight, Kindling Bio, Hope Valley AI, Skymab Biotherapeutics.
What was Paris-Saclay Cancer Cluster's most recent investment shown here?
Paris-Saclay Cancer Cluster's most recent investment in this portfolio sample was in Abbelight in 2026.
What sectors does Paris-Saclay Cancer Cluster focus on?
Paris-Saclay Cancer Cluster focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Paris-Saclay Cancer Cluster focus on?
Paris-Saclay Cancer Cluster typically invests at the Early stage.